Cyclosporin a therapy in patients with primary Sjogren's syndrome: results at one year (Journal article)

Drosos, A. A./ Skopouli, F. N./ Galanopoulou, V. K./ Kitridou, R. C./ Moutsopoulos, H. M.

We present our experience with small doses of cyclosporine A (CyA), 5 mg/kg/day, in patients with primary Sjogren's syndrome treated for up to 12 months. Subjective improvement in xerostomia occurred at 6 months of treatment, without objective improvement in any sicca parameters. At 12 months, xerostomia improved slightly, but minor salivary gland histology worsened. We conclude that small doses of CyA in patients with primary Sjogren's syndrome for up to 12 months are rather ineffective.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Clinical Trials as Topic,Cyclosporins/adverse effects/*therapeutic use,Double-Blind Method,Humans,Sjogren's Syndrome/*drug therapy
ISSN: 0301-3847
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.